Skip to main content

Security report for biocev.eu

Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University · Healthcare · Czech Republic

Medium risk. 4 critical or high findings in GDPR outside view and SSL/TLS.

Security score

74/100

Risk levelMedium

0–100, higher is better. How it is calculated

Biocev is a prominent biotechnology and biomedicine research center affiliated with the Academy of Sciences and Charles University in the Czech Republic. The organization focuses on collaborative scientific research, education, and providing advanced scientific services and facilities. Their website reflects an active institution with ongoing news, events, and educational programs targeting scientists, researchers, and students. The business model centers on research and development with a strong academic and scientific community orientation. Technically, the website is built using modern web standards including HTML5, CSS3, and JavaScript with jQuery. It employs Google Analytics for traffic monitoring and features a responsive design optimized for mobile devices. The site includes standard SEO and accessibility features, though no specific CMS or hosting provider details are evident. Performance is moderate with good navigation and content structure. From a security perspective, the site enforces HTTPS and implements a cookie consent mechanism compliant with GDPR. However, it lacks explicit security headers such as Content-Security-Policy and does not publish a vulnerability disclosure or incident response policy. No vulnerabilities or exposed sensitive data were detected in the HTML content. WHOIS data is privacy protected as per EURid policy for .eu domains, which is typical and justified for this type of institution. Overall, the website presents a professional and trustworthy digital presence with a solid security posture but could improve by adding explicit security headers and formal security policies. The risk level is low, and the site is suitable for its academic and research audience.

Scanned

NIS2 and GDPR posture

GDPR outside view
40/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      Third-party services without privacy policy

      Detected services: Google Analytics, Facebook, Twitter, LinkedIn, YouTube

      What to do: Document all third-party data sharing in your privacy policy

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching biocev.eu

This scan found 18 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
80
Email security
70
DNS health
75
Network security
100
GDPR outside view
40
Average
74

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention biocev.eu, from OffSeq Breach.

No leaked records found

Breach holds no records for biocev.eu right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Biocev operates as an important research institution in the healthcare and biotechnology sectors within the Czech Republic. Its competitive advantage lies in its collaborative environment, access to advanced scientific equipment, and integration with academic entities. The business model is primarily research and education focused, with services including genomics, cellular biology, protein engineering, and diagnostic development. The institution targets scientists, postdocs, students, and research partners. The presence of active news and events indicates ongoing growth and engagement. Partnerships and collaborations are implied but not explicitly detailed on the site. Revenue streams likely include research grants, service fees, and educational programs. The organization maintains a professional online presence with consistent branding and trust signals such as testimonials and contact transparency.

Security posture

The website demonstrates a mature security posture with mandatory HTTPS encryption and a GDPR-compliant cookie consent mechanism. No sensitive data leakage or vulnerable libraries were identified in the HTML content. However, the absence of security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options represents an area for improvement. There is no visible incident response or vulnerability disclosure policy, which could enhance transparency and preparedness. The WHOIS privacy protection is standard for .eu domains and appropriate for this academic entity. Overall, the security risks are low, but adopting additional security best practices and publishing formal policies would strengthen the security culture and compliance.

Recommendations

  1. Implement security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to mitigate common web attacks.
  2. Publish a formal security policy and incident response plan accessible on the website to improve transparency and readiness.
  3. Establish a vulnerability disclosure program or security.txt file to encourage responsible reporting of security issues.
  4. Regularly review and update privacy and cookie policies to maintain GDPR compliance and user trust.
  5. Enhance website performance optimization and monitor for any emerging security threats continuously.

Contact details published on the site

Addresses
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University
Description
Biocev is a biotechnology and biomedicine research center that facilitates collaboration among scientists from different specialties and provides access to advanced scientific equipment and services.
Key services
Functional Genomics, Cellular Biology and Virology, Structural Biology and Protein Engineering, Biomaterials and Tissue Engineering, Development of Diagnostic and Therapeutic Procedures, Phenogenomics, Imaging Methods, Mass Spectrometry, Molecular Structure Analysis, GeneCore Facility
Content quality
good
Branding
consistent

Technology

Stack
HTML5, CSS3, JavaScript, jQuery, Google Analytics
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges
  2. Content is professionally presented with clear navigation and multilingual support (English and Czech)
  3. Active news and events sections indicate ongoing activity
  4. Contact information is complete and includes phone, email, and physical address
  5. Cookie consent mechanism is implemented and GDPR policy is available
  6. No explicit security headers detected in HTML source
  7. Google Analytics is used for traffic analysis
  8. No visible vulnerabilities or exposed sensitive data in HTML
  9. WHOIS data is privacy protected as per EURid policy for .eu domains
Technical notes

Notes

The website uses a standard modern web technology stack with HTML5, CSS3, and JavaScript supported by jQuery. Google Analytics is integrated for visitor tracking. The site is mobile responsive and includes accessibility features such as ARIA labels and screen reader text. The HTML is well structured with meta tags for SEO and Open Graph tags for social media sharing. No CMS or hosting provider information is explicitly detected. Performance is moderate with no broken elements or errors observed. The site could benefit from additional technical enhancements such as security headers and improved caching strategies to optimize speed and security.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with biocev.eu. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review biocev.eu.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.